Prophylactic treatment of cytomegalovirus infection with traditional herbs

Antiviral Research

Volumn 32, Issue 2, 1996, Pages 63-70

  Yukawa, Tomoyo A ^a   Kurokawa, Masahiko ^a   Sato, Hitoshi ^a   Yoshida, Yoshihiro ^a   Kageyama, Seiji ^a   Hasegawa, Tomomi ^a   Namba, Tuneo ^a   Imakita, Masami ^b   Hozumi, Toyoharu ^c   Shiraki, Kimiyasu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c Central Research and Development Laboratory   (Japan)

Author keywords

Antiviral activity; Cyclosporine; Cytomegalovirus; Ganciclovir; Herbs; Immunosuppression; Plant extract

Indexed keywords

CYCLOSPORIN A; GANCICLOVIR; PLANT EXTRACT; TERMINALIA CHEBULA EXTRACT;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIVIRAL ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; HISTOLOGY; IMMUNE DEFICIENCY; LUNG; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALIA; BRUCEA JAVANICA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; GEUM; GEUM JAPONICUM; HERPES; MAIZE CHLOROTIC MOTTLE VIRUS; MURINAE; RHUS; SIMPLEXVIRUS; SYZYGIUM AROMATICUM; TERMINALIA CHEBULA;

EID: 0030270880     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00978-7     Document Type: Article

References (29)

1. Barnard, D.L., Huffman, J.H., Sidwell, R.W. and Reist, E.J. (1993) Selective inhibition of cytomegalovirus by 9-(3′-ethylphosphono-1′-hydroxymethyl-1′-propyloxy-methyl) guanine. Antiviral Res. 22, 77-89.
2. Betts, R.F. and Hanshaw, J.B. (1977) Cytomegalovirus (CMV) in the compromised host(s). Ann. Rev. Med. 28, 103-110.
3. Feng, J.S., Crouch J.Y., Tolman, R.L., Lucia, H.L. and Hsiung, G.D. (1992) Combined treatment with 2′-nor-cGMP and ganciclovir against cytomegalovirus infection in a guinea pig model. Antiviral Res. 19, 193-206.
4. Fong, C.K.Y., Cohen, S.D., McCormick, S. and Hsiung, G.D. (1987) Antiviral effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against cytomegalovirus infection in a guinea pig model. Antiviral Res. 7, 11-23.
5. Freitas, V.R., Fraser-Smith, E.B. and Metthews, T.R. (1989) Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo. Antiviral Res. 12, 205-212.
6. Good, A.H., Wolfsy, L., Henry, C. and Kimura, J. (1980) Modification of keyhole limpet hemocyanin with trinitrophenyl hapten. In: B.B. Mishel and S.M. Shiigi (Eds), Selected Methods in Cellular Immunology (Japanese edition), pp. 317-319. W.H. Frieman and Company, San Francisco.
7. Henry, C. and Kimura, J. (1980) Antisera to haptens. In: B.B. Mishel and S.M. Shiigi (Eds), Selected Methods in Cellular Immunology (Japanese edition), pp. 239-240. W.H. Frieman and Company, San Francisco.
8. Ho, M. (1977) Viral infections after transplantation in man. Arch. Virol. 55, 1-24.
9. Ikeda, S., Neyts, J., Matsuura, M., Kiso, M., Hasegawa, A., Nishimura, C. and De Clercq, E. (1993) Protective activity of the lipid A analogue GLA-60 against murine cytomegalovirus infection in immunodeficient mice. J. Gen. Virol. 74, 1399-1403.
10. Jacobson, M.A. and Mills, J. (1988) Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann. Intern. Med. 108, 585-594.
11. Jiangxu New Medical College (1978) Dictionary of Chinese Medicinal Materials. Shanghai Science and Technology Press, Shanghai (in Chinese).
12. Kurokawa, M., Ochiai, H., Nagasaka, K., Neki, M., Xu, H., Kadota, S., Sutardjo, S., Matsumoto, T., Namba, T. and Shiraki, K. (1993) Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antiviral Res. 22, 175-188.
13. Kurokawa, M., Nagasaka, K., Hirabayashi, T., Uyama S., Sato, H., Kageyama T., Kadota S., Oyama H., Hozumi, T., Namba, T. and Shiraki, K. (1995) Efficacy of traditional herbal medicines in combination with acyclovir against herpes simplex virus type 1 infection in vitro and in vivo. Antiviral Res. 27, 19.
14. Land, W. (1987) Optimal Use of Sandimmun in Organ Transplantation. Springer-Verlag, Berlin.
15. Marker, S.C., Howard R.J., Simmons R.L., Kalis, J.M., Connelly, D.P., Najarian, J.S. and Balfour, Jr., H.H. (1981) Cytomegalovirus infection: a quantitative prospective study of 320 consecutive renal transplants. Surgery 89, 660-671.
16. Nagasaka, K., Kurokawa, M., Imakita, M., Terasawa, K. and Shiraki, K. (1995) Efficacy of Kakkon-to, a traditional herb medicine, in herpes simplex virus type 1 infection in mice. J. Med. Virol. 46, 28-34.
17. Neyts, J., Sobis, H., Snoeck, R., Vandeputte, M. and De Clercq, E. (1993) Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice. Eur. J. Clin. Microbiol. Infect. Dis. 12, 269-279.
18. Osborn, J.E. (1982) CMV - herpesvirus of mice. In: H.L. Foster, J.G. Fox and J.D. Small (Eds), The Mouse in Biomedical Research, Vol. 2, pp. 267-292. Academic Press, New York.
19. Shanley, J.D. and Pesanti, E.L. (1985) The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection. J. Infect. Dis. 151, 454-458.
20. Shigata, S., Konno, K., Babe, M., Yokota, T. and De Clercq, E. (1991) Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro. J. Infect. Dis. 163, 270-275.
21. Shiraki, K., Ishibashi, M., Okuno, T., Kokado, Y., Takahara, S., Yamanishi, K., Sonoda, T. and Takahashi, M. (1990) Effects of cyclosporine, azathioprine, mizoribine and prednisolone on replication of human cytomegalovirus. Transplant. Proc. 22, 1682-1685.
22. Shiraki, K., Ishibashi, M., Okuno, T., Namazue, J., Yamanishi, K., Takahashi, M. and Sonoda, T. (1991a) Immunosuppressive dose of azathioprine inhibits replication of human cytomegalovirus. Arch. Virol. 117, 165-171.
23. Shiraki, K., Ishibashi, M., Okuno, T., Hayashi, K., Yamanishi, K., Takahashi, M. and Sonoda, T. (1991b) Effect of FK 506 on replication of human cytomegalovirus in vitro. J. Antibiot. 44, 909-911.
24. Snoeck, R., Sakuma, T., De Clercq, E., Rosenberg, I. and Holy, A. (1988) (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent selective inhibitor of human cytomegalovirus replication. Antimicrob. Agents Chemother. 32, 1839-1844.
25. Stals, F.S., De Clercq, E. and Bruggeman, C.A. (1991) Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo. Antimicrob. Agents Chemother. 35, 2262-2266.
26. Stals, F.S., Zeytinoglu A., Havenith, M., De Clercq, E. and Bruggeman, C.A. (1993) Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine. Antimicrob. Agents Chemother. 37, 218-223.
27. Wilson, E.J., Medearis, Jr., D.N., Hansen, L.A. and Rubin, R.H. (1987) 9-(1-3-dihydroxy-2-propoxymethyl)guanine prevents death but not immunity in murine cytomegalovirus infected normal and immunosuppressed BALB/c mice. Antimicrob. Agents Chemother. 31, 1017-1020.
28. Yamamoto, N., Yamada, Y., Daikoku, T., Nishiyama, Y., Tsutsui, Y., Shimada, N. and Takahashi, K. (1990) Antiviral effect of oxetanocin G against guinea pig cytomegalovirus infection in vitro and in vivo. J. Antibiot. 43, 1573-1578.
29. Zaia, J.A. (1993) Prevention and treatment of cytomegalovirus pneumonia in transplant recipients. Clin. Infect. Dis. 17, 5392-5399.